Results 11 to 20 of about 421,156 (296)

Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection

open access: yesJournal of Biomedical Science, 2022
The coronavirus disease 2019 (COVID-19) pandemic is an exceptional public health crisis that demands the timely creation of new therapeutics and viral detection.
Yu-Chyi Hwang   +8 more
doaj   +1 more source

Bridging the gap between emerging models and humans by learning from polio animal studies: A systematic review

open access: yesClinical and Translational Discovery, 2022
Disease modelling plays a fundamental role in biomedical research, even more in virology where the virus depends strictly on its host for replication. Although animal models are extensively used in virology, there is an increasing demand for animal‐free ...
Giulia Moreni   +9 more
doaj   +1 more source

Translating translation: Regulated protein translation as a biomedical intervention [PDF]

open access: yesFly, 2009
Altering the cellular response to internal and external stressors is essential for survival, hence the process of translation is exquisitely regulated to rapidly change the proteomic profile upon physiological challenges. We recently reported that genetic and pharmacological manipulation of translation may be beneficial in the treatment of Parkinson ...
Luke S, Tain, Alexander J, Whitworth
openaire   +2 more sources

Orally administered branaplam does not impact neurogenesis in juvenile mice, rats, and dogs

open access: yesBiology Open, 2021
Branaplam is a therapeutic agent currently in clinical development for the treatment of infants with type 1 spinal muscular atrophy (SMA). Since preclinical studies showed that branaplam had cell-cycle arrest effects, we sought to determine whether ...
Diethilde Theil   +5 more
doaj   +1 more source

Toward A Universal Biomedical Data Translator [PDF]

open access: yesClinical and Translational Science, 2018
Myriad biomedical data are available today and bring with them a need to "translate" those data into meaningful information that can be used to accelerate clinical and translational science and drive innovations in clinical care and drug discovery. We describe the work of The Biomedical Data Translator Consortium to develop a platform that supports the
Fecho, Karamarie   +22 more
openaire   +4 more sources

Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants

open access: yesJournal of Biomedical Science, 2022
Background The variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) harbor diverse spike (S) protein sequences, which can greatly influence the efficacies of therapeutics.
Shih-Han Ko   +9 more
doaj   +1 more source

Optimization and Improvement of qPCR Detection Sensitivity of SARS-CoV-2 in Saliva

open access: yesMicrobiology Spectrum, 2023
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a major public health threat globally, especially during the beginning of the pandemic in 2020.
Hui-Ying Ko   +8 more
doaj   +1 more source

Understanding the role of APOE Gene Polymorphisms in Minimal Atrophy Alzheimer’s Disease by mixture of expert models [PDF]

open access: yesE3S Web of Conferences, 2021
Alzheimer’s disease (AD) is a heterogeneous disease. Exploring the characteristics of each AD subtype is the key to disentangling the heterogeneity. Minimal atrophy AD (MAD) is a common AD subtype that yields conflicting results.
Lin Lan   +3 more
doaj   +1 more source

Progress toward a universal biomedical data translator

open access: yesClinical and Translational Science, 2022
AbstractClinical, biomedical, and translational science has reached an inflection point in the breadth and diversity of available data and the potential impact of such data to improve human health and well‐being. However, the data are often siloed, disorganized, and not broadly accessible due to discipline‐specific differences in terminology and ...
Fecho, Karamarie   +178 more
openaire   +5 more sources

Switching from blonanserin tablets to blonanserin transdermal patches improves tardive dyskinesia: A case report

open access: yesNeuropsychopharmacology Reports, 2021
Tardive dyskinesia (TD) is a common side effect of antipsychotics, and it remains a persistent and challenging problem. The blonanserin transdermal patch, developed in Japan and launched in September 2019, is the first antipsychotic transdermal treatment.
Shintaro Sakai   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy